Adverse effect of antiallergic and antiemetic drugs, subs

This code signifies an unintended, harmful reaction experienced by a patient due to the use of antiallergic or antiemetic medications. It specifically indicates that the patient is in the phase of active treatment for the adverse effect, following the initial encounter. This could involve managing symptoms, adjusting medication, or monitoring the patient's response to interventions.

Apply this code when documenting follow-up care for a patient experiencing an adverse effect from drugs like antihistamines, decongestants, or anti-nausea medications. This includes visits for continued monitoring, medication adjustments, or further treatment of the reaction after the initial assessment. It is appropriate for encounters where the focus is on managing the ongoing consequences of the drug reaction.

• Always sequence this code after the primary diagnosis indicating the nature of the adverse effect (e.g., rash, dizziness).
• Ensure the documentation clearly states the drug causing the adverse effect and that the encounter is for ongoing management.
• Verify that "subsequent encounter" is appropriate, meaning the patient is receiving active treatment for the adverse effect, not just initial diagnosis or sequelae.